v3.25.2
Acquisitions - Schedule of Preliminary Allocation of Assets Acquired and Liabilities Assumed (Details) - USD ($)
 22 Months Ended
Feb. 10, 2025
Jul. 01, 2024
Mar. 31, 2023
Feb. 10, 2025
Jun. 30, 2025
Dec. 31, 2024
Consideration:            
Cash consideration       $ 14,648,000    
Stock consideration       1,000,000    
Deferred consideration $ 179,081     179,081    
Contingent liability 16,062,190     16,062,190 $ 4,947,614 $ 4,973,152
Total consideration       31,889,271    
Recognized amounts of identifiable assets acquired and liabilities assumed            
Cash 1,728,286     1,728,286    
Accounts receivable 2,555,339     2,555,339    
Prepaid expenses 36,622     36,622    
Other current assets 682,119     682,119    
Intangible assets 18,154,990     18,154,990    
Total identifiable assets acquired 23,157,356     23,157,356    
Accounts payable 28,978     28,978    
Due to seller 3,358,907     3,358,907    
Accrued liabilities 111,223     111,223    
Other current liabilities 174,177     174,177    
Total liabilities assumed 3,673,285     3,673,285    
Noncontrolling interests 2,188,450     2,188,450    
Goodwill       10,557,200    
Additional paid-in-capital (340,450)     (340,450)    
Total purchase price 31,889,271     31,889,271    
PTI            
Consideration:            
Cash consideration 3,800,000          
Stock consideration 0          
Deferred consideration 179,081     179,081    
Contingent liability 240,000     240,000 240,000  
Total consideration 4,219,081          
Recognized amounts of identifiable assets acquired and liabilities assumed            
Cash 153,682     153,682    
Accounts receivable 521,806     521,806 521,806  
Prepaid expenses 36,622     36,622    
Other current assets 388,641     388,641 388,641  
Intangible assets 2,224,990     2,224,990    
Total identifiable assets acquired 3,325,741     3,325,741    
Accounts payable 0     0    
Due to seller 910,447     910,447 159,528  
Accrued liabilities 111,223     111,223    
Other current liabilities 0     0    
Total liabilities assumed 1,021,670     1,021,670    
Noncontrolling interests 0     0    
Goodwill 1,915,010          
Additional paid-in-capital 0     0    
Total purchase price $ 4,219,081     $ 4,219,081    
Ambulnz CO            
Consideration:            
Cash consideration   $ 1,848,000        
Stock consideration   0        
Deferred consideration   0        
Contingent liability   0        
Total consideration   1,848,000        
Recognized amounts of identifiable assets acquired and liabilities assumed            
Cash   0        
Accounts receivable   0        
Prepaid expenses   0        
Other current assets   0        
Intangible assets   0        
Total identifiable assets acquired   0        
Accounts payable   0        
Due to seller   0        
Accrued liabilities   0        
Other current liabilities   0        
Total liabilities assumed   0        
Noncontrolling interests   2,188,450        
Goodwill   0        
Additional paid-in-capital   (340,450)        
Total purchase price   $ 1,848,000        
CRMS            
Consideration:            
Cash consideration     $ 9,000,000      
Stock consideration     1,000,000      
Deferred consideration     0      
Contingent liability     15,822,190   $ 4,707,614 $ 4,707,614
Total consideration     25,822,190      
Recognized amounts of identifiable assets acquired and liabilities assumed            
Cash     1,574,604      
Accounts receivable     2,033,533      
Prepaid expenses     0      
Other current assets     293,478      
Intangible assets     15,930,000      
Total identifiable assets acquired     19,831,615      
Accounts payable     28,978      
Due to seller     2,448,460      
Accrued liabilities     0      
Other current liabilities     174,177      
Total liabilities assumed     2,651,615      
Noncontrolling interests     0      
Goodwill     8,642,190      
Additional paid-in-capital     0      
Total purchase price     $ 25,822,190